CHANGES IN MBS BULK BILLING INCENTIVES ADDRESS GP CAPACITY IN WOMEN’S HEALTH Reforms expand professional pathways and clinical scope to meet the demands of patients
With
Dr Sneha Wadhwani, GP
Bondi Junction Medical & Dental Centre &
Conjoint Lecturer, UNSW Medical School &
Clinical Director NSW & ACT,
Head of GP Wellbeing & Women’s Health,
ForHealth Group &
Co-Founder & National Clinical Director
Evoca Women’s Health
SEGMENT
Filmed in Sydney | November 2025
Dr. Sneha Wadhwani, a General Practitioner in Bondi, and Conjoint Lecturer at UNSW School of Medicine, is actively involved in enhancing women’s health services across Australia. As the Co-founder and Clinical Director of Evoca Women’s Health, she highlights the significant improvements in funding for women’s health, particularly with the new MBS bulk billing incentives, in new codes, that commenced on November 1, 2025.
These codes facilitate bulk billing for essential services such as menopause health assessments and long-acting reversible contraceptives, enabling more women to access critical care at little or no cost. These advancements address long-standing challenges faced by GPs, including time constraints and inadequate funding, which have historically limited comprehensive women’s health care delivery.
The investment in training for IUDs and contraceptive implants is another vital component of this initiative, equipping more GPs to provide these services effectively. Dr. Wadhwani notes that the Evoca model prioritises GP-led, holistic care, with trained practitioners working alongside allied health professionals to support women through various stages of their lives.
With the expansion of Evoca clinics from one to 43 nationally and an expectation that 75% will eventually adopt bulk billing, Dr Wadhwani believes there is a significant opportunity for GPs interested in women’s health to upskill and serve women who have previously delayed care due to costs. Dr. Wadhwani emphasises that addressing women’s health has far-reaching effects on families and communities, creating a compelling call to action for clinicians to embrace these new incentives.
Source: Adapted from transcript
-
Surgeon-scientist path laid for medical device research
In 2022, Distinguished Professor Gordon Wallace AO and Professor Mukherjee jointly established Beyond Science as a clinician led, academically supported and clinician run Australian-first medical technology translation program.
The program is aimed at early career researchers and clinician-scientists working in medical device research specifically in otolaryngology (ear, nose, and throat), head and neck surgery.
-
Reporting on Australian childhood visual impairment: the first 10 years
The Australian Childhood Vision Impairment Register (ACVIR), the first of its kind in Australia, captures uniquely Australian data which is used to improve services for children with vision impairment. The data is also available to researchers who work in the area of eye disease and disorders of vision.
-
New Generative AI and machine learning frontier on unused patient care data
Drawing from GE’s 125-year legacy in healthcare, Amit Yadav, CEO GE HealthCare ANZ is leading efforts to integrate AI into medical imaging devices and optimise workflow efficiencies. He stresses the importance of leveraging the vast amount of untapped healthcare data, with an emphasis on automating manual processes to enhance productivity. Additionally, his focus extends to utilising AI for workflow optimisation and ensuring compliance with local regulations and standards to prioritise safety.
